Information  X 
Enter a valid email address

Benchmark Hlgs PLC (BMK)

  Print   

Monday 19 April, 2021

Benchmark Hlgs PLC

Notice of Q2 and Interim Results

RNS Number : 7967V
Benchmark Holdings PLC
19 April 2021
 

19 April 2021

 

Benchmark Holdings plc

 

("Benchmark" or the "Company")

 

Notice of Q2 and Interim Results

 

Webcast for analysts and institutional investors

Equity Development webcast for retail investors

 

Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business, will announce its Q2 and Interim results for the three and six month periods ended 31 March 2021, on Tuesday 18 May 2021. 

 

Webcast for analysts and institutional investors at 9am UK time

 

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a webcast for analysts and institutional investors on that day at 09:00am UK time. To register your interest, please contact  [email protected] .

 

Equity Development webcast for retail investors at 12:30pm UK time

 

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a separate webcast for retail investors and wealth managers at 12.30pm UK time. The webcast is open to all existing and potential shareholders. Questions can be submitted during the presentation which will be addressed at the end.

 

To register please visit:   https://www.equitydevelopment.co.uk/news-and-events/benchmark-holdings-interim-results-investor-presentation-18th-may-2021

 

 

  Enquiries

For further information, please contact:

 

Benchmark Holdings plc

Tel:  020 3696 0630

Trond Williksen, CEO

 

Septima Maguire, CFO

 

Ivonne Cantu, Investor Relations

 

 

 

Numis (Broker and NOMAD)

Tel:  020 7260 1000

James Black, Freddie Barnfield, Duncan Monteith

 

 

 

MHP Communications

Tel:  020 3128 8990

Katie Hunt, Reg Hoare, Alistair de Kare-Silver, Charlie Protheroe

[email protected]

 

Equity Development

Hannah Crowe

 

Tel:  020 7065 2690

 

 

 

About Benchmark

Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.

We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORIFMFTMTTBBPB

a d v e r t i s e m e n t